Status:
UNKNOWN
Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 As Biomarkers of AKI in Children With DKA
Lead Sponsor:
Assiut University
Conditions:
Diabetes Mellitius
Eligibility:
All Genders
1-18 years
Brief Summary
Type 1 diabetes mellitus (T1DM) is a common, chronic, metabolic disorder that has significant consequences for physical and emotional development . The incidence of TIDM is steadily increasing in near...
Detailed Description
Type 1 diabetes mellitus (T1DM) is a common, chronic, metabolic disorder that has significant consequences for physical and emotional development. The incidence of TIDM is steadily increasing in nearl...
Eligibility Criteria
Inclusion
- All patients with diabetic ketoacidosis below 18 years whether first time or recurrent ketoacidosis with either increase in serum creatinine more than or equal 0.3 mg/dl within 48hrs or to more than or equal 1.5 times or more baseline within 7 days or urine output less than 0.5 mL/kg/h for 6 hours.(22)
Exclusion
- Patients with known renal disease before first attack of diabetic ketoacidosis
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06032325
Start Date
January 1 2024
End Date
December 1 2024
Last Update
September 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.